Role of Dendritic Cells in Viral Brain Infections

To gain access to the brain, a so-called immune-privileged organ due to its physical separation from the blood stream, pathogens and particularly viruses have been selected throughout evolution for their use of specific mechanisms. They can enter the central nervous system through direct infection o...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 13; no. 5; p. 862053
Main Authors: Constant, Orianne, Maarifi, Ghizlane, Blanchet, Fabien P, Van de Perre, Philippe, Simonin, Yannick, Salinas, Sara
Format: Journal Article
Language:English
Published: Switzerland Frontiers 22-04-2022
Frontiers Media S.A
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To gain access to the brain, a so-called immune-privileged organ due to its physical separation from the blood stream, pathogens and particularly viruses have been selected throughout evolution for their use of specific mechanisms. They can enter the central nervous system through direct infection of nerves or cerebral barriers or through cell-mediated transport. Indeed, peripheral lymphoid and myeloid immune cells can interact with the blood-brain and the blood-cerebrospinal fluid barriers and allow viral brain access using the "Trojan horse" mechanism. Among immune cells, at the frontier between innate and adaptive immune responses, dendritic cells (DCs) can be pathogen carriers, regulate or exacerbate antiviral responses and neuroinflammation, and therefore be involved in viral transmission and spread. In this review, we highlight an important contribution of DCs in the development and the consequences of viral brain infections.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMCID: PMC9072653
Edited by: Michael H. Lehmann, Ludwig-Maximilians-Universität München, Germany
Reviewed by: Aditya Rayasam, Medical College of Wisconsin, United States; Andrew Nicholas Harman, The University of Sydney, Australia
These authors have contributed equally to this work
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.862053